Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticoagulant therapy for recurrent spontaneous abortion with thrombophilia
ChiCTR-IPR-16009417Phase 4Recruiting
- Sponsor
- Shanghai First Maternal and Infant Health Hospital
- Start
- Nov 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of low molecular weight heparin calcium and aspirin in Hypercoagulability and recurrent miscarriage (RPL) (3 arms), sponsored by Shanghai First Maternal and Infant Health Hospital. Primary endpoints: fetal chromosome analysis, antithrombin (AT) level and 9 more. Started Nov 2016; status: recruiting.
02
Drugs
low molecular weight heparin calciumaspirin
03
Conditions
Hypercoagulabilityrecurrent miscarriage (RPL)
Beyond the preview
Go deeper on ChiCTR-IPR-16009417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009417.